The purpose of this study is to evaluate if differences between samples of subjects obtained before autologous blood transfusion or samples of non-transfused subjects and samples of subjects after autologous blood transfusion can be identified. Analyses performed will focus on the morphological and biochemical parameters of red blood cells and associated microparticles. The final goal would be to find markers of autologous blood transfusion, that could be used to identify such doping practice.
Age range
18 Years – 35 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in hematological parameters
Timeframe: Baseline (Day 1), until 2 days after autotransfusion
Change in hematological parameters
Timeframe: Baseline (Day 1), until 2 days after autotransfusion
Change in hematological parameters
Timeframe: Baseline (Day 1), until 2 days after autotransfusion
Change in hematological parameters
Timeframe: Baseline (Day 1), until 2 days after autotransfusion
Change in hematological parameters
Timeframe: Baseline (Day 1), until 2 days after autotransfusion
Variation in Red blood cells morphology
Timeframe: Baseline (Day 1), until 2 days after autotransfusion
Change in expression of cell surface proteins in red blood cells transfusion
Timeframe: Baseline (Day 1), until 2 days after autotransfusion
Change in microparticles detected in plasma
Timeframe: Baseline (Day 1), until 2 days after autotransfusion